drugset / Trial / NCT07633600
Phenotype Guided Vasoactive Medication During Kidney Transplantation
NaSingle-groupOpen-labelPrevention
Summary
The goal of this clinical trial is to learn if vasopressin improves the body's response to intravenous fluids during kidney transplantation in patients who have relaxed blood vessels. Researchers will compare the results of vasopressin to those who received calcium chloride.
Timeline
- Start
- 2026-06-01
- Primary completion
- 2027-06-01
- Completion
- 2027-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calcium Chloride | Unknown | — | — |
| Subject | Dopamine | Small molecule | — | Other |
| Subject | Norepinephrine | Other / unclassified | — | Other |
| Subject | Vasopressin | Peptide | — | Other |
Indications
No indication recorded.